News

Hosted on MSN3mon
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to ... neuroscience leader with the drug’s manufacturer, Johnson & Johnson, said in a news release.
Hosted on MSN1mon
FDA Approves Nasal Spray for Depression
The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment ... the manufacturer Johnson & Johnson said in a press release. The study found that ...
pharmaphorum3d
FDA approves Janssen’s ketamine-based nasal antidepressant
The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...